These indicators are considered to be predictors of tumor immunotherapy response (29–31), so the analysis of the correlation between the expression level of PPA2 and these indicators is also to observe the immune value of PPA2 in the treatment of different tumors. The gene discussed is PPA2; the disease is neoplasm.